News Archive
Futura Medical due $5m milestone payment from Haleon
7th Oct 2024 14:17
(Sharecast News) - Futura Medical, the consumer healthcare company behind Eroxon, announced on Monday that a $5m milestone payment had been triggered under its agreement with consumer products giant Haleon.
Read moreCora reports positive analysis results from Tambir gold anomaly
7th Oct 2024 14:08
(Sharecast News) - Cora Gold reported positive results from multi-element analysis on Monday, following its recent reconnaissance drilling programme at the Tambor gold anomaly in the Madina Foulbé exploration permit area, eastern Senegal.
Read moreFTSE 250 movers: Lancashire falls on Hurricane Milton fears
7th Oct 2024 14:08
(Sharecast News) - FTSE 250 (MCX) 20,845.05 -0.26%
Read moreJohn Lewis CEO to step back from role as chairman takes on duties
7th Oct 2024 13:36
(Sharecast News) - John Lewis Partnership chief executive Nish Kankiwala is stepping back from his role next spring, as the retail company announced it was axing the role and passing on more duties to chair Jason Tarry.
Read moreApollo to buy Barnes Group in $3.6bn deal
7th Oct 2024 12:44
(Sharecast News) - Technology and aerospace manufacturer Barnes Group said on Monday that it has agreed to be bought by Apollo Global Management for $3.6bn in cash.
Read moreSerabi releases updated Coringa economic assessment
7th Oct 2024 11:55
(Sharecast News) - Serabi Gold released an updated preliminary economic assessment (PEA) for its wholly-owned Coringa Gold Project in Brazil's Para state on Monday, including improved project economics.
Read moreVast Resources now expecting sales proceeds later in October
7th Oct 2024 11:41
(Sharecast News) - Mining company Vast Resources updated the market on its short-term funding situation on Monday, saying that it now expected to receive proceeds from sales around the third week of October, helping to address its immediate financial requirements.
Read moreEurope midday: Shares edge lower; Oil prices above $78 on MEast tensions
7th Oct 2024 11:37
(Sharecast News) - European shares were lower on Monday as investors eyed the impact of the latest round of tit-for-tat attacks in the Middle East between Israel and most of its neighbours.
Read moreChevron Canada to sell assets to Canadian Natural for $6.5bn
7th Oct 2024 11:30
(Sharecast News) - Chevron Canada said on Monday that it has agreed to sell its 20% interest in the Athabasca Oil Sands Project (AOSP) to Canadian Natural Resources for $6.5bn in cash.
Read moreLondon midday: Stocks turn up as energy issues gain
7th Oct 2024 10:59
(Sharecast News) - London stocks had turned higher by midday on Monday, with energy issues providing a boost as the conflict in the Middle East lifted oil prices, and as investors mulled another uptick in UK house prices.
Read moreUS pre-open: Futures points to losses as traders look ahead to Q3 earnings season
7th Oct 2024 10:51
(Sharecast News) - Wall Street futures were in the red ahead of the bell on Monday as major indices looked set to fall short of picking up where they left off in the previous session as investors look ahead to the beginning of Q3 earnings season later in the week.
Read moreSolid State wins 'two significant contracts' in US defence sector
7th Oct 2024 10:50
(Sharecast News) - Value-added components supplier Solid State has been awarded "two significant contracts" with a combined value of $5.1m from two leading defence prime contractors for battery packs to be used in the US defence sector.
Read moreSosandar signs lease in Cardiff for fourth store
7th Oct 2024 10:34
(Sharecast News) - Women's fashion brand Sosandar announced the signing of a lease for its fourth store on Monday, in Cardiff's St David's shopping centre.
Read moreFD Technologies agrees £230m sale of First Derivative business
7th Oct 2024 10:28
(Sharecast News) - FD Technologies announced an agreement to sell its First Derivative business to EPAM Systems on Monday, for £230m.
Read morehVIVO upbeat on positive human challenge trial results with client
7th Oct 2024 10:21
(Sharecast News) - Specialist contract research organisation hVIVO announced positive results from a phase 2a human challenge trial (HCT) for Enanta Pharmaceuticals' RSV antiviral candidate, EDP-323, on Monday.
Read more